Publications

Publications by Chantal M.E. Tallaksen

107 publications found

Publications 2019

  1. Rydning SL, Koht J, Sheng Y, Sowa P, Hjorthaug HS, Wedding IM, Erichsen AK, Hovden IA, Backe PH, Tallaksen CME, Vigeland MD, Selmer KK (2019)
    Biallelic POLR3A variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis
    Brain, 142 (4), e12
    DOI 10.1093/brain/awz041, PubMed 30847471
  2. Stenshorne I, Rasmussen M, Salvanos P, Tallaksen CME, Bindoff LA, Koht J (2019)
    Fever-related ataxia: a case report of CAPOS syndrome
    Cerebellum Ataxias, 6, 2
    DOI 10.1186/s40673-019-0096-3, PubMed 31410291

Publications 2018

  1. Arntzen KA, Høyer H, Ørstavik K, Tallaksen C, Vedeler C, Østern R, Nebuchennykh M, Braathen GJ, Fagerheim T (2018)
    Charcot-Marie-Tooth disease type 4C in Norway: Clinical characteristics, mutation spectrum and minimum prevalence
    Neuromuscul Disord, 28 (8), 639-645
    DOI 10.1016/j.nmd.2018.06.004, PubMed 30001926
  2. Coutelier M, Hammer MB, Stevanin G, Monin ML, Davoine CS, Mochel F, Labauge P, Ewenczyk C, Ding J, Gibbs JR, Hannequin D, Melki J, Toutain A, Laugel V, Forlani S, Charles P, Broussolle E, Thobois S, Afenjar A, Anheim M, Calvas P, Castelnovo G, de Broucker T, Vidailhet M, Moulignier A et al. (2018)
    Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes
    JAMA Neurol, 75 (5), 591-599
    DOI 10.1001/jamaneurol.2017.5121, PubMed 29482223
  3. Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA (2018)
    Elevated cerebrospinal fluid protein in POLG-related epilepsy: Diagnostic and prognostic implications
    Epilepsia, 59 (8), 1595-1602
    DOI 10.1111/epi.14459, PubMed 29920680
  4. Hikmat O, Tzoulis C, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, McFarland R, Rahman S, Bindoff LA (2018)
    Erratum to: The presence of anaemia negatively influences survival in patients with POLG disease
    J Inherit Metab Dis, 41 (1), 153
    DOI 10.1007/s10545-017-0092-9, PubMed 28952135
  5. Parodi L, Fenu S, Barbier M, Banneau G, Duyckaerts C, Tezenas du Montcel S, Monin ML, Ait Said S, Guegan J, Tallaksen CME, Sablonniere B, Brice A, Stevanin G, Depienne C, Durr A, SPATAX network (2018)
    Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex
    Brain, 141 (12), 3331-3342
    DOI 10.1093/brain/awy285, PubMed 30476002
  6. Rydning SL, Dudesek A, Rimmele F, Funke C, Krüger S, Biskup S, Vigeland MD, Hjorthaug HS, Sejersted Y, Tallaksen C, Selmer KK, Kamm C (2018)
    A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia
    Eur J Neurol, 25 (7), 943-e71
    DOI 10.1111/ene.13625, PubMed 29528531
  7. Samuelsson K, Radovic A, Press R, Auranen M, Ylikallio E, Tyynismaa H, KäRppä M, Veteläinen M, Peltola N, Mellgren SI, Mygland Å, Tallaksen C, Andersen H, Terkelsen AJ, Fontain F, Hietaharju A (2018)
    Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small-fiber and mixed neuropathy
    Muscle Nerve, 59 (3), 354-357
    DOI 10.1002/mus.26348, PubMed 30246259
  8. Sjaastad O, Blau N, Rydning SL, Peters V, Rødningen O, Stray-Pedersen A, Krossnes B, Tallaksen C, Koht J (2018)
    Homocarnosinosis: A historical update and findings in the SPG11 gene
    Acta Neurol Scand, 138 (3), 245-250
    DOI 10.1111/ane.12949, PubMed 29732542

Publications 2017

  1. Boldingh MI, Maniaol A, Brunborg C, Dekker L, Lipka A, Niks EH, Verschuuren J, Tallaksen C (2017)
    Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe
    Muscle Nerve, 55 (6), 819-827
    DOI 10.1002/mus.25408, PubMed 27641227
  2. Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, Schöls L, Synofzik M, Sturm M, Tallaksen C, Wedding IM, Boesch S, Eigentler A, van de Warrenburg B, van Gaalen J, Kamm C, Dudesek A, Kang JS, Timmann D, Silvestri G, Masciullo M, Klopstock T, Neuhofer C, Ganos C, Filla A et al. (2017)
    Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia
    Neurology, 89 (10), 1043-1049
    DOI 10.1212/WNL.0000000000004311, PubMed 28794257
  3. Hikmat O, Tzoulis C, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, McFarland R, Rahman S, Bindoff LA (2017)
    The presence of anaemia negatively influences survival in patients with POLG disease
    J Inherit Metab Dis, 40 (6), 861-866
    DOI 10.1007/s10545-017-0084-9, PubMed 28865037
  4. Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CM, Toft M (2017)
    Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
    PLoS One, 12 (3), e0174667
    DOI 10.1371/journal.pone.0174667, PubMed 28362824
  5. Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CME, Toft M (2017)
    Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
    PLoS One, 12 (10), e0186571
    DOI 10.1371/journal.pone.0186571, PubMed 29023604
  6. Rydning SL, Backe PH, Sousa MML, Iqbal Z, Øye AM, Sheng Y, Yang M, Lin X, Slupphaug G, Nordenmark TH, Vigeland MD, Bjørås M, Tallaksen CM, Selmer KK (2017)
    Novel UCHL1 mutations reveal new insights into ubiquitin processing
    Hum Mol Genet, 26 (6), 1217-1218
    DOI 10.1093/hmg/ddx072, PubMed 28334853
  7. Rydning SL, Backe PH, Sousa MML, Iqbal Z, Øye AM, Sheng Y, Yang M, Lin X, Slupphaug G, Nordenmark TH, Vigeland MD, Bjørås M, Tallaksen CM, Selmer KK (2017)
    Novel UCHL1 mutations reveal new insights into ubiquitin processing
    Hum Mol Genet, 26 (6), 1031-1040
    DOI 10.1093/hmg/ddw391, PubMed 28007905
  8. Tallaksen CM, Müller U (2017)
    Cancer and neurodegeneration: Time to move beyond Janus?
    Neurology, 88 (12), 1106-1107
    DOI 10.1212/WNL.0000000000003727, PubMed 28202693

Publications 2016

  1. Boldingh MI, Maniaol AH, Brunborg C, Weedon-Fekjær H, Verschuuren JJ, Tallaksen CM (2016)
    Increased risk for clinical onset of myasthenia gravis during the postpartum period
    Neurology, 87 (20), 2139-2145
    DOI 10.1212/WNL.0000000000003339, PubMed 27770065
  2. Gilhus NE, Kerty E, Løseth S, Mygland Å, Tallaksen C (2016)
    [Myasthenia gravis - optimal treatment and accurate diagnosis]
    Tidsskr Nor Laegeforen, 136 (12-13), 1089-94
    DOI 10.4045/tidsskr.15.1259, PubMed 27381787
  3. Jahic A, Erichsen AK, Deufel T, Tallaksen CM, Beetz C (2016)
    A polymorphic Alu insertion that mediates distinct disease-associated deletions
    Eur J Hum Genet, 24 (9), 1371-4
    DOI 10.1038/ejhg.2016.20, PubMed 26932189
  4. Koht J, Løstegaard SO, Wedding I, Vidailhet M, Louha M, Tallaksen CM (2016)
    Benign hereditary chorea, not only chorea: a family case presentation
    Cerebellum Ataxias, 3, 3
    DOI 10.1186/s40673-016-0041-7, PubMed 26839702
  5. Paap BK, Roeske S, Durr A, Schöls L, Ashizawa T, Boesch S, Bunn LM, Delatycki MB, Giunti P, Lehéricy S, Mariotti C, Melegh J, Pandolfo M, Tallaksen CME, Timmann D, Tsuji S, Schulz JB, van de Warrenburg BP, Klockgether T (2016)
    Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies
    Mov Disord Clin Pract, 3 (3), 230-240
    DOI 10.1002/mdc3.12315, PubMed 30363623
  6. Rydning SL, Wedding IM, Koht J, Chawla M, Øye AM, Sheng Y, Vigeland MD, Selmer KK, Tallaksen CM (2016)
    A founder mutation p.H701P identified as a major cause of SPG7 in Norway
    Eur J Neurol, 23 (4), 763-71
    DOI 10.1111/ene.12937, PubMed 26756429
  7. Simonsen CS, Celius EG, Brunborg C, Tallaksen C, Eriksen EF, Holmøy T, Moen SM (2016)
    Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
    BMC Neurol, 16 (1), 252
    DOI 10.1186/s12883-016-0771-4, PubMed 27919248
  8. Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B et al. (2016)
    Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen
    J Neuroimmunol, 292, 108-15
    DOI 10.1016/j.jneuroim.2016.01.018, PubMed 26943968

Publications 2015

  1. Boldingh MI, Dekker L, Maniaol AH, Brunborg C, Lipka AF, Niks EH, Verschuuren JJ, Tallaksen CM (2015)
    An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts
    Health Qual Life Outcomes, 13, 115
    DOI 10.1186/s12955-015-0298-1, PubMed 26232146
  2. Boldingh MI, Maniaol AH, Brunborg C, Dekker L, Heldal AT, Lipka AF, Popperud TH, Niks EH, Verschuuren JJ, Tallaksen CM (2015)
    Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries
    Neuroepidemiology, 44 (4), 221-31
    DOI 10.1159/000431036, PubMed 26068011
  3. Coutelier M, Goizet C, Durr A, Habarou F, Morais S, Dionne-Laporte A, Tao F, Konop J, Stoll M, Charles P, Jacoupy M, Matusiak R, Alonso I, Tallaksen C, Mairey M, Kennerson M, Gaussen M, Schule R, Janin M, Morice-Picard F, Durand CM, Depienne C, Calvas P, Coutinho P, Saudubray JM et al. (2015)
    Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia
    Brain, 138 (Pt 8), 2191-205
    DOI 10.1093/brain/awv143, PubMed 26026163
  4. Horn MA, Mikaelsen KB, Ferdinandusse S, Jørum E, Mellgren SI, Retterstøl L, Wanders RJ, Tallaksen CM (2015)
    Mild phenotype in an adult male with X-linked adrenoleukodystrophy - case report
    Clin Case Rep, 4 (2), 177-81
    DOI 10.1002/ccr3.434, PubMed 26862418
  5. Monin ML, Tezenas du Montcel S, Marelli C, Cazeneuve C, Charles P, Tallaksen C, Forlani S, Stevanin G, Brice A, Durr A (2015)
    Survival and severity in dominant cerebellar ataxias
    Ann Clin Transl Neurol, 2 (2), 202-7
    DOI 10.1002/acn3.156, PubMed 25750924
  6. Tsonis AI, Zisimopoulou P, Lazaridis K, Tzartos J, Matsigkou E, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A et al. (2015)
    MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study
    J Neuroimmunol, 284, 10-7
    DOI 10.1016/j.jneuroim.2015.04.015, PubMed 26025053
  7. Wedding IM, Kroken M, Henriksen SP, Selmer KK, Fiskerstrand T, Knappskog PM, Berge T, Tallaksen CM (2015)
    Friedreich ataxia in Norway - an epidemiological, molecular and clinical study
    Orphanet J Rare Dis, 10, 108
    DOI 10.1186/s13023-015-0328-4, PubMed 26338206

Publications 2014

  1. Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C et al. (2014)
    VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
    Ann Clin Transl Neurol, 1 (5), 329-39
    DOI 10.1002/acn3.51, PubMed 25356403
  2. Heimdal K, Sanchez-Guixé M, Aukrust I, Bollerslev J, Bruland O, Jablonski GE, Erichsen AK, Gude E, Koht JA, Erdal S, Fiskerstrand T, Haukanes BI, Boman H, Bjørkhaug L, Tallaksen CM, Knappskog PM, Johansson S (2014)
    STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneity
    Orphanet J Rare Dis, 9, 146
    DOI 10.1186/s13023-014-0146-0, PubMed 25258038
  3. Horn MA, Nilsen KB, Jørum E, Mellgren SI, Tallaksen CM (2014)
    Small nerve fiber involvement is frequent in X-linked adrenoleukodystrophy
    Neurology, 82 (19), 1678-83
    DOI 10.1212/WNL.0000000000000415, PubMed 24719486
  4. Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2014)
    Age-dependent penetrance among females with X-linked adrenoleukodystrophy
    Brain, 138 (Pt 2), e325
    DOI 10.1093/brain/awu232, PubMed 25149409
  5. Koht J, Rengmark A, Opladen T, Bjørnarå KA, Selberg T, Tallaksen CM, Blau N, Toft M (2014)
    Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene
    Acta Neurol Scand Suppl (198), 7-12
    DOI 10.1111/ane.12230, PubMed 24588500
  6. Wedding IM, Koht J, Tran GT, Misceo D, Selmer KK, Holmgren A, Frengen E, Bindoff L, Tallaksen CM, Tzoulis C (2014)
    Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions
    PLoS One, 9 (1), e86340
    DOI 10.1371/journal.pone.0086340, PubMed 24466038

Publications 2013

  1. Horn MA, Erichsen MM, Wolff AS, Månsson JE, Husebye ES, Tallaksen CM, Skjeldal OH (2013)
    Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease
    Clin Endocrinol (Oxf), 79 (3), 316-20
    DOI 10.1111/cen.12159, PubMed 23346902
  2. Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2013)
    Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance
    Pediatr Neurol, 48 (3), 212-9
    DOI 10.1016/j.pediatrneurol.2012.12.007, PubMed 23419472
  3. Sumathipala DS, Abeysekera GS, Jayasekara RW, Tallaksen CM, Dissanayake VH (2013)
    Autosomal dominant hereditary ataxia in Sri Lanka
    BMC Neurol, 13, 39
    DOI 10.1186/1471-2377-13-39, PubMed 23634774
  4. Wedding IM, Koht J, Dietrichs E, Landrø NI, Tallaksen CM (2013)
    Cognition is only minimally impaired in Spinocerebellar ataxia type 14 (SCA14): a neuropsychological study of ten Norwegian subjects compared to intrafamilial controls and population norm
    BMC Neurol, 13, 186
    DOI 10.1186/1471-2377-13-186, PubMed 24289098
  5. Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P et al. (2013)
    A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
    J Autoimmun, 52, 139-45
    DOI 10.1016/j.jaut.2013.12.004, PubMed 24373505

Publications 2012

  1. Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, Simpfendorfer KR, Pirskanen-Matell R, Piehl F, Pan-Hammarstrom Q, Verschuuren JJ, Titulaer MJ, Niks EH, Marx A, Ströbel P, Tackenberg B, Pütz M, Maniaol A, Elsais A, Tallaksen C, Harbo HF, Lie BA, Raychaudhuri S, de Bakker PI, Melms A et al. (2012)
    Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08
    Ann Neurol, 72 (6), 927-35
    DOI 10.1002/ana.23691, PubMed 23055271
  2. Maniaol AH, Boldingh M, Brunborg C, Harbo HF, Tallaksen CM (2012)
    Smoking and socio-economic status may affect myasthenia gravis
    Eur J Neurol, 20 (3), 453-60
    DOI 10.1111/j.1468-1331.2012.03843.x, PubMed 22934661
  3. Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF (2012)
    Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population
    PLoS One, 7 (5), e36603
    DOI 10.1371/journal.pone.0036603, PubMed 22590574
  4. Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribai P, Vincitorio C, Anheim M, Guyant-Maréchal L, Le Bayon A, Vandenberghe N, Tchikviladzé M, Devos D, Le Ber I, N'Guyen K, Cazeneuve C, Tallaksen C, Brice A, Durr A (2012)
    Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia
    Arch Neurol, 69 (4), 500-8
    DOI 10.1001/archneurol.2011.2713, PubMed 22491195

Publications 2011

  1. Alseth EH, Maniaol AH, Elsais A, Nakkestad HL, Tallaksen C, Gilhus NE, Skeie GO (2011)
    Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients
    Muscle Nerve, 43 (4), 574-7
    DOI 10.1002/mus.21919, PubMed 21305573
  2. Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Finsterer J, EFNS (2011)
    EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders
    Eur J Neurol, 18 (2), 207-17
    DOI 10.1111/j.1468-1331.2010.03069.x, PubMed 20500522
  3. Holmøy T, Braaten Ø, Hovden IA, Tallaksen CM (2011)
    [A young woman with a weakening leg]
    Tidsskr Nor Laegeforen, 131 (6), 583-6
    DOI 10.4045/tidsskr.09.1499, PubMed 21423311
  4. Koht J, Stevanin G, Durr A, Mundwiller E, Brice A, Tallaksen CM (2011)
    SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene
    Acta Neurol Scand, 125 (2), 116-22
    DOI 10.1111/j.1600-0404.2011.01504.x, PubMed 21434874

Publications 2010

  1. Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Gasser T, EFNS (2010)
    EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias
    Eur J Neurol, 17 (5), 641-8
    DOI 10.1111/j.1468-1331.2010.02985.x, PubMed 20298421
  2. Maniaol AH, Brunborg C, Tallaksen CM (2010)
    Development and validation of a self-administered questionnaire for myasthenia gravis patients
    Neuroepidemiology, 34 (4), 253-61
    DOI 10.1159/000297753, PubMed 20299807
  3. Schlipf NA, Beetz C, Schüle R, Stevanin G, Erichsen AK, Forlani S, Zaros C, Karle K, Klebe S, Klimpe S, Durr A, Otto S, Tallaksen CM, Riess O, Brice A, Bauer P, Schöls L (2010)
    A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42)
    Eur J Hum Genet, 18 (9), 1065-7
    DOI 10.1038/ejhg.2010.68, PubMed 20461110
  4. Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L, Lamperti C, Tallaksen CM, Duffey P, Miller J, Whittaker RG, Baker MR, Jackson MJ, Clarke MP, Dhillon B, Czermin B, Stewart JD, Hudson G, Reynier P, Bonneau D, Marques W et al. (2010)
    Multi-system neurological disease is common in patients with OPA1 mutations
    Brain, 133 (Pt 3), 771-86
    DOI 10.1093/brain/awq007, PubMed 20157015

Publications 2009

  1. Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM (2009)
    Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study
    Brain, 132 (Pt 6), 1577-88
    DOI 10.1093/brain/awp056, PubMed 19339254
  2. Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Gasser T, European Federation of Neurological Sciences (2009)
    EFNS guidelines on the molecular diagnosis of mitochondrial disorders
    Eur J Neurol, 16 (12), 1255-64
    DOI 10.1111/j.1468-1331.2009.02811.x, PubMed 19950421
  3. Gasser T, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Harbo HF, EFNS (2009)
    EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias
    Eur J Neurol, 17 (2), 179-88
    DOI 10.1111/j.1468-1331.2009.02873.x, PubMed 20050888
  4. Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, Stevanin G, Brice A (2009)
    Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10
    Hum Mutat, 30 (2), E376-85
    DOI 10.1002/humu.20920, PubMed 18853458
  5. Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, Zeviani M, Burgunder JM, Gasser T, EFNS (2009)
    EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias
    Eur J Neurol, 16 (7), 777-85
    DOI 10.1111/j.1468-1331.2009.02646.x, PubMed 19469830
  6. Koht J, Bjørnarå KA, Jørum E, Tallaksen CM (2009)
    Ataxia with vitamin E deficiency in southeast Norway, case report
    Acta Neurol Scand Suppl (189), 42-5
    DOI 10.1111/j.1600-0404.2009.01214.x, PubMed 19566498
  7. Selmer KK, Eriksson AS, Brandal K, Egeland T, Tallaksen C, Undlien DE (2009)
    Parental SCN1A mutation mosaicism in familial Dravet syndrome
    Clin Genet, 76 (4), 398-403
    DOI 10.1111/j.1399-0004.2009.01208.x, PubMed 19673951
  8. Tallaksen CM, Berg JE (2009)
    Miglustat therapy in juvenile Sandhoff disease
    J Inherit Metab Dis, 32 Suppl 1, S289-93
    DOI 10.1007/s10545-009-1224-7, PubMed 19898953
  9. Vevelstad M, Pettersen S, Tallaksen C, Brørs O (2009)
    O-demethylation of codeine to morphine inhibited by low-dose levomepromazine
    Eur J Clin Pharmacol, 65 (8), 795-801
    DOI 10.1007/s00228-009-0640-9, PubMed 19308365

Publications 2008

  1. Erichsen AK, Server A, Landrø NI, Sandvik L, Tallaksen CM (2008)
    Proton magnetic resonance spectroscopy and cognition in patients with spastin mutations
    J Neurol Sci, 277 (1-2), 124-9
    DOI 10.1016/j.jns.2008.10.030, PubMed 19084842
  2. Erichsen AK, Stevanin G, Denora P, Brice A, Tallaksen CM (2008)
    SPG11--the most common type of recessive spastic paraplegia in Norway?
    Acta Neurol Scand Suppl, 188, 46-50
    DOI 10.1111/j.1600-0404.2008.01031.x, PubMed 18439221
  3. Tallaksen CM (2008)
    [Hereditary ataxias]
    Tidsskr Nor Laegeforen, 128 (17), 1977-80
    PubMed 18787576

Publications 2007

  1. Erichsen AK, Inderhaug E, Mattingsdal M, Eiklid K, Tallaksen CM (2007)
    Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia
    Eur J Neurol, 14 (7), 809-14
    DOI 10.1111/j.1468-1331.2007.01861.x, PubMed 17594340
  2. Horn MA, van den Brink DM, Wanders RJ, Duran M, Poll-The BT, Tallaksen CM, Stokke OH, Moser H, Skjeldal OH (2007)
    Phenotype of adult Refsum disease due to a defect in peroxin 7
    Neurology, 68 (9), 698-700
    DOI 10.1212/01.wnl.0000255960.01644.39, PubMed 17325280
  3. Koht J, Tallaksen CM (2007)
    Cerebellar ataxia in the eastern and southern parts of Norway
    Acta Neurol Scand Suppl, 187, 76-9
    DOI 10.1111/j.1600-0404.2007.00853.x, PubMed 17419835
  4. Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, Rosa AL, Lerer I, Hamri A, Alegria P, Loureiro J, Tada M, Hannequin D, Anheim M, Goizet C, Gonzalez-Martinez V, Le Ber I, Forlani S, Iwabuchi K, Meiner V, Uyanik G, Erichsen AK, Feki I, Pasquier F, Belarbi S et al. (2007)
    Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration
    Brain, 131 (Pt 3), 772-84
    DOI 10.1093/brain/awm293, PubMed 18079167

Publications 2006

  1. Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribaï P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A (2006)
    Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia
    J Med Genet, 44 (4), 281-4
    DOI 10.1136/jmg.2006.046425, PubMed 17098887
  2. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0555
    Hum Genet, 118 (6), 782
    PubMed 17297711
  3. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hs0516
    Hum Genet, 118 (6), 785
    PubMed 17297722
  4. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
    Gene symbol: SPAST (SPG4). Disease: Spastic paraparesis. Accession #Hm0552
    Hum Genet, 118 (6), 781
    PubMed 17297708
  5. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0556
    Hum Genet, 118 (6), 782
    PubMed 17297712
  6. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0553
    Hum Genet, 118 (6), 782
    PubMed 17297709
  7. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0557
    Hum Genet, 118 (6), 783
    PubMed 17297713
  8. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0554
    Hum Genet, 118 (6), 782
    PubMed 17297710
  9. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: spastic paraparesis. Accession #Hs0515
    Hum Genet, 118 (6), 785
    PubMed 17297721
  10. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
    Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hd0519
    Hum Genet, 118 (6), 776
    PubMed 17297686
  11. Elleuch N, Depienne C, Benomar A, Hernandez AM, Ferrer X, Fontaine B, Grid D, Tallaksen CM, Zemmouri R, Stevanin G, Durr A, Brice A (2006)
    Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia
    Neurology, 66 (5), 654-9
    DOI 10.1212/01.wnl.0000201185.91110.15, PubMed 16534102
  12. Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, Tallaksen C, Berrih-Aknin S (2006)
    The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
    Blood, 108 (2), 432-40
    DOI 10.1182/blood-2005-06-2383, PubMed 16543475

Publications 2005

  1. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2005)
    Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases
    J Med Genet, 43 (3), 259-65
    DOI 10.1136/jmg.2005.035311, PubMed 16055926

Publications 2004

  1. Dietrichs E, Tallaksen CM (2004)
    [Genetics in movement disorders--dystonia, tremor and chorea]
    Tidsskr Nor Laegeforen, 124 (17), 2236-7
    PubMed 15356687
  2. Dürr A, Camuzat A, Colin E, Tallaksen C, Hannequin D, Coutinho P, Fontaine B, Rossi A, Gil R, Rousselle C, Ruberg M, Stevanin G, Brice A (2004)
    Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia
    Arch Neurol, 61 (12), 1867-72
    DOI 10.1001/archneur.61.12.1867, PubMed 15596607
  3. Tallaksen CM, Dietrichs E (2004)
    [The genetics of movement disorders--spinocerebellar degenerations]
    Tidsskr Nor Laegeforen, 124 (17), 2233-5
    PubMed 15356686

Publications 2003

  1. Tallaksen CM, Guichart-Gomez E, Verpillat P, Hahn-Barma V, Ruberg M, Fontaine B, Brice A, Dubois B, Durr A (2003)
    Subtle cognitive impairment but no dementia in patients with spastin mutations
    Arch Neurol, 60 (8), 1113-8
    DOI 10.1001/archneur.60.8.1113, PubMed 12925368

Publications 2002

  1. Jacquemont ML, Campion D, Hahn V, Tallaksen C, Frebourg T, Brice A, Durr A (2002)
    Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease
    J Med Genet, 39 (2), E2
    DOI 10.1136/jmg.39.2.e2, PubMed 11836371

Publications 2001

  1. Tallaksen CM, Dürr A, Brice A (2001)
    Recent advances in hereditary spastic paraplegia
    Curr Opin Neurol, 14 (4), 457-63
    DOI 10.1097/00019052-200108000-00005, PubMed 11470961

Publications 2000

  1. Tallaksen CM, Taubøll E (2000)
    Excitatory effect of thiamin on CA1 pyramidal neurones in rat hippocampal slices in vitro
    Eur J Neurol, 7 (6), 693-8
    DOI 10.1046/j.1468-1331.2000.00132.x, PubMed 11136357

Publications 1999

  1. Tallaksen CM, Taubøll E, Nome T (1999)
    [Normal pressure hydrocephalus--evaluation of investigation procedures]
    Tidsskr Nor Laegeforen, 119 (12), 1744-9
    PubMed 10380589

Publications 1998

  1. Tallaksen CM, Bovim G (1998)
    [Thiamine treatment today]
    Tidsskr Nor Laegeforen, 118 (25), 3946-9
    PubMed 9830340
  2. Tallaksen CM, Kerty E, Bakke S (1998)
    Visual hallucinations in a case of reversible hypertension-induced brain oedema
    Eur J Neurol, 5 (6), 615-618
    DOI 10.1046/j.1468-1331.1998.560615.x, PubMed 10210899

Publications 1997

  1. Tallaksen CM, Bøhmer T, Karlsen J, Bell H (1997)
    Determination of thiamin and its phosphate esters in human blood, plasma, and urine
    Methods Enzymol, 279, 67-74
    DOI 10.1016/s0076-6879(97)79010-4, PubMed 9211258
  2. Tallaksen CM, Jetne V, Fosså S (1997)
    Postradiation lower motor neuron syndrome--a case report and brief literature review
    Acta Oncol, 36 (3), 345-7
    DOI 10.3109/02841869709001276, PubMed 9208910

Publications 1994

  1. Bell H, Tallaksen CM, Try K, Haug E (1994)
    Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department
    Alcohol Clin Exp Res, 18 (5), 1103-8
    DOI 10.1111/j.1530-0277.1994.tb00088.x, PubMed 7847591
  2. Bøhmer T, Utzon P, Tallaksen C (1994)
    [Scurvy with simultaneous wet beriberi in 2 patients]
    Tidsskr Nor Laegeforen, 114 (27), 3181-3
    PubMed 7809869
  3. Tallaksen CM, Bell H, Bøhmer T (1994)
    Elevated plasma thiamin concentrations in patients with rhabdomyolysis
    Clin Nutr, 13 (2), 123-4
    DOI 10.1016/0261-5614(94)90071-x, PubMed 16843371

Publications 1993

  1. Bell H, Tallaksen C, Sjåheim T, Weberg R, Raknerud N, Orjasaeter H, Try K, Haug E (1993)
    Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases
    Alcohol Clin Exp Res, 17 (2), 246-52
    DOI 10.1111/j.1530-0277.1993.tb00757.x, PubMed 8488962
  2. Tallaksen CM, Bell H, Bøhmer T (1993)
    Thiamin and thiamin phosphate ester deficiency assessed by high performance liquid chromatography in four clinical cases of Wernicke encephalopathy
    Alcohol Clin Exp Res, 17 (3), 712-6
    DOI 10.1111/j.1530-0277.1993.tb00825.x, PubMed 8333605
  3. Tallaksen CM, Sande A, Bøhmer T, Bell H, Karlsen J (1993)
    Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally
    Eur J Clin Pharmacol, 44 (1), 73-8
    DOI 10.1007/bf00315284, PubMed 8436160

Publications 1992

  1. Tallaksen CM, Bell H, Bøhmer T (1992)
    The concentration of thiamin and thiamin phosphate esters in patients with alcoholic liver cirrhosis
    Alcohol Alcohol, 27 (5), 523-30
    PubMed 1476555
  2. Tallaksen CM, Bøhmer T, Bell H (1992)
    Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment
    Alcohol Clin Exp Res, 16 (2), 320-5
    DOI 10.1111/j.1530-0277.1992.tb01384.x, PubMed 1317136
  3. Tallaksen CM, Bøhmer T, Bell H (1992)
    Concentrations of the water-soluble vitamins thiamin, ascorbic acid, and folic acid in serum and cerebrospinal fluid of healthy individuals
    Am J Clin Nutr, 56 (3), 559-64
    DOI 10.1093/ajcn/56.3.559, PubMed 1503069

Publications 1991

  1. Tallaksen CM, Bøhmer T, Bell H, Karlsen J (1991)
    Concomitant determination of thiamin and its phosphate esters in human blood and serum by high-performance liquid chromatography
    J Chromatogr, 564 (1), 127-36
    DOI 10.1016/0378-4347(91)80075-n, PubMed 1860908
 
Page visits: 3165